Endologix Company Profile (NASDAQ:ELGX)

About Endologix

Endologix logoEndologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Its EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: ELGX
  • CUSIP: 29266S10
Key Metrics:
  • Previous Close: $11.55
  • 50 Day Moving Average: $13.04
  • 200 Day Moving Average: $11.01
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -17.77
  • P/E Growth: -0.44
  • Market Cap: $951.40M
  • Outstanding Shares: 82,372,000
  • Beta: 0.72
Additional Links:
Companies Related to Endologix:

Analyst Ratings

Consensus Ratings for Endologix (NASDAQ:ELGX) (?)
Ratings Breakdown: 2 Hold Ratings, 9 Buy Ratings
Consensus Rating:Buy (Score: 2.82)
Consensus Price Target: $13.86 (20.03% upside)

Analysts' Ratings History for Endologix (NASDAQ:ELGX)
Show:
DateFirmActionRatingPrice TargetDetails
8/3/2016BMO Capital MarketsReiterated RatingBuy$15.00View Rating Details
8/3/2016BTIG ResearchReiterated RatingBuy$16.00View Rating Details
8/3/2016Piper Jaffray Cos.Reiterated RatingOverweight$15.00View Rating Details
8/3/2016Oppenheimer Holdings Inc.Set Price TargetBuy$16.00 -> $15.00View Rating Details
8/3/2016RBC Capital MarketsDowngradeOutperform -> Sector Perform$17.00 -> $12.00View Rating Details
8/3/2016Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$17.00 -> $12.00View Rating Details
7/12/2016Canaccord GenuityReiterated RatingBuyView Rating Details
6/8/2016GuggenheimInitiated CoverageBuy$16.00View Rating Details
4/4/2016JPMorgan Chase & Co.Initiated CoverageOverweight$11.00View Rating Details
2/22/2016Credit Suisse Group AGLower Price TargetOutperform$16.00 -> $10.00View Rating Details
2/2/2016Stifel NicolausLower Price TargetBuy$17.00 -> $15.00View Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for Endologix (NASDAQ:ELGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2016        
8/2/2016Q2($0.20)($0.13)$46.30 million$51.00 millionViewListenView Earnings Details
5/9/2016Q1($0.24)($0.25)$38.78 million$42.40 millionViewN/AView Earnings Details
2/22/2016Q4($0.16)($0.17)$39.97 million$39.20 millionViewListenView Earnings Details
10/26/2015Q315($0.14)($0.13)$38.12 million$38.20 millionViewListenView Earnings Details
8/3/2015Q215($0.13)($0.18)$39.47 million$39.50 millionViewN/AView Earnings Details
4/29/2015Q115($0.13)($0.14)$37.94 million$36.70 millionViewN/AView Earnings Details
2/25/2015Q414($0.10)($0.11)$38.10 million$38.80 millionViewN/AView Earnings Details
10/30/2014Q314($0.13)($0.13)$37.00 million$37.20 millionViewListenView Earnings Details
7/30/2014Q214($0.08)($0.06)$36.50 million$38.30 millionViewListenView Earnings Details
4/30/2014Q114($0.08)($0.08)$32.24 million$33.30 millionViewListenView Earnings Details
2/27/2014Q413($0.05)($0.05)$35.80 million$35.25 millionViewListenView Earnings Details
10/30/2013Q313($0.05)$0.01$32.47 million$33.30 millionViewN/AView Earnings Details
7/30/2013Q2 2013($0.06)($0.03)$33.94 million$34.00 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.06)($0.15)$29.26 million$29.80 millionViewN/AView Earnings Details
2/27/2013Q4 2012($0.03)($0.09)$29.03 million$29.22 millionViewN/AView Earnings Details
10/25/2012($0.04)($0.03)ViewN/AView Earnings Details
7/26/2012($0.04)($0.09)ViewN/AView Earnings Details
4/26/2012($0.06)($0.07)ViewN/AView Earnings Details
2/22/2012($0.05)($0.06)ViewN/AView Earnings Details
10/27/2011($0.05)($0.09)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Endologix (NASDAQ:ELGX)
Current Year EPS Consensus Estimate: $-0.74 EPS
Next Year EPS Consensus Estimate: $-0.65 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.24)($0.24)($0.24)
Q2 20161($0.22)($0.22)($0.22)
Q3 20161($0.17)($0.17)($0.17)
Q4 20161($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Endologix (NASDAQ:ELGX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Endologix (NASDAQ:ELGX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/19/2016Jose A LimaVPSell4,710$11.68$55,012.80View SEC Filing  
8/5/2016Michael V ChobotovInsiderSell14,000$12.40$173,600.00View SEC Filing  
6/3/2016Gregory D WallerDirectorSell7,800$12.86$100,308.00View SEC Filing  
6/1/2016Amanda L DepalmaVPSell689$12.55$8,646.95View SEC Filing  
6/1/2016John D McdermottCEOSell6,116$12.55$76,755.80View SEC Filing  
6/1/2016Joseph A DejohnInsiderSell957$12.55$12,010.35View SEC Filing  
6/1/2016Robert D MitchellPresidentSell2,294$12.55$28,789.70View SEC Filing  
5/26/2016James Edward MachekVPSell6,500$12.76$82,940.00View SEC Filing  
1/26/2016Charles Steele LoveVPSell4,280$7.72$33,041.60View SEC Filing  
11/3/2015Guido J NeelsDirectorBuy11,000$9.32$102,520.00View SEC Filing  
11/3/2015Todd AbrahamVPBuy2,500$8.85$22,125.00View SEC Filing  
11/2/2015John D McdermottCEOBuy20,000$8.90$178,000.00View SEC Filing  
9/3/2015Jose A LimaVPSell1,923$12.60$24,229.80View SEC Filing  
5/26/2015Thomas WilderDirectorSell3,790$16.08$60,943.20View SEC Filing  
5/20/2015Jose A LimaVPSell1,872$16.75$31,356.00View SEC Filing  
4/6/2015Robert D MitchellPresidentSell45,000$17.33$779,850.00View SEC Filing  
12/12/2014Charles Steele LoveVPSell10,000$13.95$139,500.00View SEC Filing  
11/18/2014Charles Steele LoveVPBuy2,000$11.70$23,400.00View SEC Filing  
11/4/2014Guido J NeelsDirectorBuy10,000$11.21$112,100.00View SEC Filing  
11/4/2014John D McdermottCEOBuy25,000$11.25$281,250.00View SEC Filing  
8/4/2014Thomas WilderDirectorSell3,500$13.68$47,880.00View SEC Filing  
6/12/2014Robert D MitchellPresidentSell18,271$14.23$259,996.33View SEC Filing  
6/10/2014Robert D MitchellPresidentSell8,516$14.20$120,927.20View SEC Filing  
8/14/2013Stefan SchreckVPSell25,000$16.18$404,500.00View SEC Filing  
8/13/2013Stefan SchreckVPSell29,000$15.88$460,520.00View SEC Filing  
8/5/2013Gary SorsherVPSell12,483$15.98$199,478.34View SEC Filing  
8/5/2013John McdermottCEOSell165,000$16.00$2,640,000.00View SEC Filing  
8/2/2013Todd AbrahamVPSell9,994$15.90$158,904.60View SEC Filing  
8/1/2013John D McdermottCEOSell15,000$15.83$237,450.00View SEC Filing  
6/3/2013Thomas WilderDirectorSell22,500$13.25$298,125.00View SEC Filing  
5/28/2013Leonard M GreensteinVPSell1,253$14.01$17,554.53View SEC Filing  
12/28/2012Robert John KristCFOSell37,530$14.06$527,671.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Endologix (NASDAQ:ELGX)
DateHeadline
News IconRetail & Analyst Ratings Forecasts on Endologix, Inc. (NASDAQ:ELGX) - Post News (NASDAQ:ELGX)
www.kentuckypostnews.com - August 23 at 9:05 AM
zacks.com logoEndologix's Ovation Alto System Treats First Patients (NASDAQ:ELGX)
www.zacks.com - August 22 at 9:27 AM
News IconStocks Preparing To Gain Concentrations- Endologix Inc. (NASDAQ ... - Seneca Globe (NASDAQ:ELGX)
www.senecaglobe.com - August 18 at 10:10 PM
streetinsider.com logoEndologix (ELGX) Announces Treatment of First AAA Patients with Ovation Alto ASGS (NASDAQ:ELGX)
www.streetinsider.com - August 18 at 4:51 PM
streetinsider.com logoEndologix (ELGX) Announces Treatment of First AAA Patients with ... - StreetInsider.com (NASDAQ:ELGX)
www.streetinsider.com - August 18 at 6:55 AM
News IconEndologix Announces First Patients Treated with Ovation Alto Abdominal Stent Graft System (NASDAQ:ELGX)
www.pressreleasepoint.com - August 17 at 5:01 PM
publicnow.com logoEndologix Announces First Patients Treated with Ovation Alto™ Abdominal Stent Graft System (NASDAQ:ELGX)
www.publicnow.com - August 17 at 5:01 PM
investornewswire.com logoEarnings Surprise In Focus: Endologix, Inc. (NASDAQ:ELGX) - Investor Newswire (NASDAQ:ELGX)
www.investornewswire.com - August 17 at 6:52 AM
finance.yahoo.com logoENDOLOGIX INC /DE/ Financials (NASDAQ:ELGX)
finance.yahoo.com - August 16 at 4:51 PM
fidaily.com logoArrowpoint Asset Management, LLC Buys A Lot More Endologix, Inc. (ELGX) Stock Last Quarter - Finance Daily (NASDAQ:ELGX)
www.fidaily.com - August 15 at 4:56 PM
fidaily.com logoEndologix, Inc. (ELGX) Holdings Down in Latest Report from Cadian Capital Management, Lp - Finance Daily (NASDAQ:ELGX)
www.fidaily.com - August 12 at 4:50 PM
istreetwire.com logoStocks Buzz: Endologix Inc. (ELGX) F.N.B. Corporation (FNB) UDR, Inc. (UDR) - iStreetWire (NASDAQ:ELGX)
istreetwire.com - August 10 at 12:04 PM
tmcnet.com logoVivek Jayaraman Appointed as Cerus Corporation's Chief Commercial Officer (NASDAQ:ELGX)
it.tmcnet.com - August 9 at 3:28 PM
capitalcube.com logoEndologix, Inc. :ELGX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:ELGX)
www.capitalcube.com - August 9 at 3:28 PM
capitalcube.com logoETF’s with exposure to Endologix, Inc. : August 5, 2016 (NASDAQ:ELGX)
www.capitalcube.com - August 5 at 4:51 PM
streetupdates.com logoAnalysts Observing Trading Stocks: Endologix, Inc. (NASDAQ:ELGX) , UnitedHealth Group Incorporated (NYSE:UNH) - Street Updates (NASDAQ:ELGX)
www.streetupdates.com - August 5 at 7:47 AM
equities.com logoEndologix Inc. (ELGX) Drops 12.84% on August 03 - Equities.com (NASDAQ:ELGX)
www.equities.com - August 5 at 7:47 AM
biz.yahoo.com logoENDOLOGIX INC /DE/ Files SEC form 10-Q, Quarterly Report (NASDAQ:ELGX)
biz.yahoo.com - August 5 at 7:47 AM
nasdaq.com logoCommit To Purchase Endologix At $10, Earn 12% Annualized Using Options (NASDAQ:ELGX)
www.nasdaq.com - August 4 at 5:01 PM
capitalcube.com logoEndologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : August 4, 2016 (NASDAQ:ELGX)
www.capitalcube.com - August 4 at 5:01 PM
finance.yahoo.com logoEndologix to Present at the 36th Annual Canaccord Genuity Growth Conference (NASDAQ:ELGX)
finance.yahoo.com - August 4 at 5:01 PM
fortune.com logoWhy Endologix, Inc. (NASDAQ:ELGX) have been downgraded? - Review Fortune (NASDAQ:ELGX)
reviewfortune.com - August 4 at 7:31 AM
News IconRussia: United States covering up election intrigue by demonising country (NASDAQ:ELGX)
bolsafinanzas.com - August 3 at 4:58 PM
benzinga.com logoPiper Jaffray Rates Endologix Overweight, Thinks Nellix Aneurysm Treatment Is 'Highly Approvable' (NASDAQ:ELGX)
www.benzinga.com - August 3 at 4:58 PM
News IconEndologix Inc. (ELGX) to Release Earnings on Tuesday (NASDAQ:ELGX)
learningandfinance.com - August 3 at 4:58 PM
thestreet.com logoWhy Endologix (ELGX) Stock Is Tumbling Today (NASDAQ:ELGX)
www.thestreet.com - August 3 at 4:58 PM
fool.com logoWhy Endologix, Inc. Is Down 13% Today (NASDAQ:ELGX)
www.fool.com - August 3 at 4:43 PM
seekingalpha.com logoEndologix tumbles on possible product delay (NASDAQ:ELGX)
seekingalpha.com - August 3 at 12:46 PM
streetupdates.com logoTraders Focused Stocks: EPIRUS Biopharmaceuticals, Inc ... - Street Updates (NASDAQ:ELGX)
www.streetupdates.com - August 2 at 10:24 PM
sg.finance.yahoo.com logoEndologix reports 2Q loss (NASDAQ:ELGX)
sg.finance.yahoo.com - August 2 at 10:24 PM
biz.yahoo.com logoENDOLOGIX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:ELGX)
biz.yahoo.com - August 2 at 4:57 PM
publicnow.com logoEndologix Reports Results for the Second Quarter 2016 (NASDAQ:ELGX)
www.publicnow.com - August 2 at 4:57 PM
biz.yahoo.com logoEndologix Inc Earnings Call scheduled for 5:00 pm ET today (NASDAQ:ELGX)
biz.yahoo.com - August 2 at 4:57 PM
biz.yahoo.com logoQ2 2016 Endologix Inc Earnings Release - After Market Close (NASDAQ:ELGX)
biz.yahoo.com - August 2 at 9:37 AM
fortune.com logoEndologix Inc. (NASDAQ:ELGX) Stock Rises, Analysts: Buy Rating ... - Review Fortune (NASDAQ:ELGX)
reviewfortune.com - July 30 at 7:52 AM
News IconThe Key Numbers To Watch From Endologix Inc. (NASDAQ:ELGX)'s Earnings - The Voice Registrar (NASDAQ:ELGX)
voiceregistrar.com - July 28 at 3:31 PM
News IconEndologix, Inc. (NASDAQ:ELGX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:ELGX)
www.engelwooddaily.com - July 22 at 7:50 AM
News IconEquity Roundup: Stock Performance Focus on Endologix, Inc. (NASDAQ:ELGX) - Press Telegraph (NASDAQ:ELGX)
presstelegraph.com - July 20 at 7:55 AM
News IconShare Performance Summary for: Endologix Inc. (NASDAQ:ELGX) - Press Telegraph (NASDAQ:ELGX)
presstelegraph.com - July 19 at 4:53 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Endologix, Inc. (NASDAQ:ELGX) - TGP (NASDAQ:ELGX)
telanaganapress.com - July 19 at 4:53 PM
News IconStock Focus: Following Analyst Expectations on Shares of Endologix, Inc. (NASDAQ:ELGX) - TGP (NASDAQ:ELGX)
telanaganapress.com - July 19 at 4:53 PM
News IconShares Moving Down on the Week: Endologix Inc. (NASDAQ:ELGX) - Engelwood Daily (NASDAQ:ELGX)
www.engelwooddaily.com - July 17 at 9:19 AM
News IconEndologix Incorporated (NASDAQ:ELGX) Short Interest Increased By 25.37% - Press Telegraph (NASDAQ:ELGX)
presstelegraph.com - July 14 at 4:27 PM
News IconAnalyst Target and Average Rating Watch: Endologix, Inc. (NASDAQ:ELGX) - Press Telegraph (NASDAQ:ELGX)
presstelegraph.com - July 14 at 5:19 AM
News IconStock Providing Gains on the Month for Investors: Endologix Inc. (NASDAQ:ELGX) - Telanagana Press (NASDAQ:ELGX)
telanaganapress.com - July 12 at 10:08 PM
News IconStock Performance Rundown on: Endologix Inc. (NASDAQ:ELGX) - Press Telegraph (NASDAQ:ELGX)
presstelegraph.com - July 12 at 10:08 PM
News IconHow Many Endologix, Inc. (NASDAQ:ELGX)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:ELGX)
www.consumereagle.com - July 12 at 10:08 PM
finance.yahoo.com logoEndologix to Report Second Quarter 2016 Financial Results on August 2, 2016 (NASDAQ:ELGX)
finance.yahoo.com - July 12 at 9:00 AM
investornewswire.com logoWill Endologix, Inc. (NASDAQ:ELGX) Surprise Analysts? - Investor Newswire (NASDAQ:ELGX)
www.investornewswire.com - July 9 at 8:18 AM
streetupdates.com logoAnalysts Review of Stocks: Exelixis, Inc. (NASDAQ:EXEL) , Endologix, Inc. (NASDAQ:ELGX) - Street Updates (NASDAQ:ELGX)
www.streetupdates.com - July 9 at 8:18 AM

Social

Endologix (NASDAQ:ELGX) Chart for Wednesday, August, 24, 2016


Last Updated on 8/24/2016 by MarketBeat.com Staff